AR040121A1 - Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer - Google Patents
Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimerInfo
- Publication number
- AR040121A1 AR040121A1 ARP030101849A ARP030101849A AR040121A1 AR 040121 A1 AR040121 A1 AR 040121A1 AR P030101849 A ARP030101849 A AR P030101849A AR P030101849 A ARP030101849 A AR P030101849A AR 040121 A1 AR040121 A1 AR 040121A1
- Authority
- AR
- Argentina
- Prior art keywords
- inhibitors
- acetilcoline
- esterase
- alzheimer
- disease
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 108090000371 Esterases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 title 1
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 229960003530 donepezil Drugs 0.000 abstract 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 abstract 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 229960003980 galantamine Drugs 0.000 abstract 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 abstract 1
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 abstract 1
- 229960004640 memantine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960004136 rivastigmine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960001685 tacrine Drugs 0.000 abstract 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200844 | 2002-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040121A1 true AR040121A1 (es) | 2005-03-16 |
Family
ID=28051666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101849A AR040121A1 (es) | 2002-05-31 | 2003-05-27 | Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR101016927B1 (ru) |
| CN (1) | CN1655793A (ru) |
| AR (1) | AR040121A1 (ru) |
| CA (1) | CA2426492C (ru) |
| EA (1) | EA007632B1 (ru) |
| IS (1) | IS7558A (ru) |
| PE (1) | PE20040623A1 (ru) |
| UA (1) | UA82480C2 (ru) |
| ZA (1) | ZA200409147B (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA107653U (uk) | 2012-10-01 | 2016-06-24 | Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" | Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів |
| CN118239847A (zh) * | 2014-05-29 | 2024-06-25 | 广州喜鹊医药有限公司 | 具有神经保护作用的金刚烷胺硝酸酯化合物的制备方法 |
| WO2018062941A1 (ko) * | 2016-09-30 | 2018-04-05 | 주식회사 바이오파마티스 | 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| KR20210072569A (ko) | 2019-12-09 | 2021-06-17 | 주식회사 종근당 | 도네페질 및 메만틴을 포함하는 복합 제제 |
-
2003
- 2003-05-08 CA CA002426492A patent/CA2426492C/en not_active Expired - Fee Related
- 2003-05-22 KR KR1020047019333A patent/KR101016927B1/ko not_active Ceased
- 2003-05-22 CN CNA038121611A patent/CN1655793A/zh active Pending
- 2003-05-22 UA UA20041109789A patent/UA82480C2/ru unknown
- 2003-05-22 EA EA200401617A patent/EA007632B1/ru not_active IP Right Cessation
- 2003-05-27 AR ARP030101849A patent/AR040121A1/es unknown
- 2003-05-29 PE PE2003000527A patent/PE20040623A1/es not_active Application Discontinuation
-
2004
- 2004-11-11 ZA ZA200409147A patent/ZA200409147B/en unknown
- 2004-11-26 IS IS7558A patent/IS7558A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA007632B1 (ru) | 2006-12-29 |
| KR20050024296A (ko) | 2005-03-10 |
| KR101016927B1 (ko) | 2011-02-28 |
| CA2426492C (en) | 2006-10-03 |
| IS7558A (is) | 2004-11-26 |
| UA82480C2 (ru) | 2008-04-25 |
| ZA200409147B (en) | 2006-06-28 |
| EA200401617A1 (ru) | 2005-06-30 |
| PE20040623A1 (es) | 2004-09-11 |
| CN1655793A (zh) | 2005-08-17 |
| CA2426492A1 (en) | 2003-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE414519T1 (de) | Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit | |
| ECSP066313A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| ECSP066315A (es) | Derivados de la piridazina y su uso como agentes terapéuticos | |
| LU92853I2 (fr) | Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et l'emtricitabine | |
| ES2193391T3 (es) | Antagonistas muscarinicos. | |
| BG66085B1 (bg) | Фенилаланинови производни | |
| ATE449081T1 (de) | Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen | |
| ECSP066312A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
| CO5570667A2 (es) | Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades | |
| DE69833971D1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
| AR034362A1 (es) | Compuestos analgesicos de liberacion prolongada | |
| AR041089A1 (es) | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas | |
| UY26839A1 (es) | Productos de derivados de la 4 - fenil - piridina | |
| AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| CO5011095A1 (es) | Inhibidores de acetilcolinestarasa en combinacion con ago- nistas muscarinicos para el tratamiento de la enfermedad de alzheimer | |
| ATE519486T1 (de) | Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer | |
| NI200200095A (es) | "composiciones farmacéuticas de amlodipina y atorvastatina" | |
| MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
| ES2045182T3 (es) | Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. | |
| EA200200207A1 (ru) | Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы | |
| PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |